Arabic Arabic English English French French German German
dark

Survival rate of patients with relapsed ALL after hematopoietic cell transplantation has steadily increased

For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic stem cell transplantation (HCT), the two-year overall survival rate has nearly doubled from the period between 2000 and 2004 to the period between 2015 and 2019, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19

Next Post

Pig heart recipient continues to recover from transplant

Related Posts
Total
0
Share